Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101
Heliostar Drills 88 m Grading 8.82 g/t Gold in Resource Conversion Drilling and Adds Third Drill Rig at Ana Paula